Constantin d’Ydewalle

1.5k total citations
16 papers, 997 citations indexed

About

Constantin d’Ydewalle is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cancer Research. According to data from OpenAlex, Constantin d’Ydewalle has authored 16 papers receiving a total of 997 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Cellular and Molecular Neuroscience and 4 papers in Cancer Research. Recurrent topics in Constantin d’Ydewalle's work include Hereditary Neurological Disorders (4 papers), Neurogenetic and Muscular Disorders Research (3 papers) and RNA modifications and cancer (3 papers). Constantin d’Ydewalle is often cited by papers focused on Hereditary Neurological Disorders (4 papers), Neurogenetic and Muscular Disorders Research (3 papers) and RNA modifications and cancer (3 papers). Constantin d’Ydewalle collaborates with scholars based in Belgium, United States and United Kingdom. Constantin d’Ydewalle's co-authors include Ludo Van Den Bosch, Pieter Vanden Berghe, Joy Irobi, Alan P. Kozikowski, Philip Van Damme, Vincent Timmerman, Wim Robberecht, Elke Bogaert, Jyothsna Krishnan and Charlotte J. Sumner and has published in prestigious journals such as Nature Medicine, Neuron and Journal of Neuroscience.

In The Last Decade

Constantin d’Ydewalle

15 papers receiving 981 citations

Peers

Countries citing papers authored by Constantin d’Ydewalle

Since Specialization

Citations

This map shows the geographic impact of Constantin d’Ydewalle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Constantin d’Ydewalle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Constantin d’Ydewalle more than expected).

Fields of papers citing papers by Constantin d’Ydewalle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Constantin d’Ydewalle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Constantin d’Ydewalle. The network helps show where Constantin d’Ydewalle may publish in the future.

Co-authorship network of co-authors of Constantin d’Ydewalle

This figure shows the co-authorship network connecting the top 25 collaborators of Constantin d’Ydewalle. A scholar is included among the top collaborators of Constantin d’Ydewalle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Constantin d’Ydewalle. Constantin d’Ydewalle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	The MIR-NAT MAPT-AS1 does not regulate Tau expression in human neurons 2025 ·PLoS ONE ·(unknown), Leen Wolfs, Saúl Martínez‐Montero, (unknown), Inès Royaux, Gert Van Peer, Pieter Mestdagh, Bart De Strooper, Annerieke Sierksma, Constantin d’Ydewalle	0
2	Regulation of human microglial gene expression and function via RNAase-H active antisense oligonucleotides in vivo in Alzheimer’s disease 2024 ·Molecular Neurodegeneration ·(unknown), Ivana Geric, Laura Fumagalli, Mohamed Kreir, Ashley Lu, Annelies Nonneman, (unknown), Leen Wolfs, (unknown), Nicola Fattorelli, An De Bondt, Ilse Van den Wyngaert, Bob Asselbergh, Mark Fiers, Bart De Strooper, Constantin d’Ydewalle, Renzo Mancuso	4
3	Development of a new hazard scoring system in primary neuronal cell cultures for drug-induced acute neuronal toxicity identification in early drug discovery 2024 ·Frontiers in Pharmacology ·Mohamed Kreir, (unknown), Fetene Tekle, (unknown), Constantin d’Ydewalle, Karel Van Ammel, Helena Geys, Ard Teisman, David J. Gallacher, Hua Rong Lu	2
4	From Junk to Function: LncRNAs in CNS Health and Disease 2021 ·Frontiers in Molecular Neuroscience ·(unknown), Annerieke Sierksma, Bart De Strooper, Constantin d’Ydewalle	49
5	Missing lnc(RNAs) in Alzheimer’s Disease? 2021 ·Genes ·(unknown), Constantin d’Ydewalle	11
6	Motor neuron loss in SMA is not associated with somal stress-activated JNK/c-Jun signaling 2019 ·Human Molecular Genetics ·(unknown), Jae Hong Park, Lingling Kong, Constantin d’Ydewalle, David Valdivia, Karen Chen, Irene Griswold‐Prenner, Charlotte J. Sumner	9
7	Genetically Engineered iPSC-Derived FTDP-17 MAPT Neurons Display Mutation-Specific Neurodegenerative and Neurodevelopmental Phenotypes 2018 ·Stem Cell Reports ·An Verheyen, Annick Diels, Joke Reumers, Kirsten Van Hoorde, Ilse Van den Wyngaert, Constantin d’Ydewalle, An De Bondt, Jacobine Kuijlaars, Louis De Muynck, Ronald De Hoogt, Alexis Bretteville, Steffen Jaensch, Arjan Buist, Alfredo Cabrera‐Socorro, Selina Wray, Andreas Ebneth, Peter Roevens, Inès Royaux, Pieter J. Peeters	43
8	HDAC6 is a therapeutic target in mutant GARS-induced Charcot-Marie-Tooth disease 2017 ·Brain ·Veronick Benoy, Lawrence Van Helleputte, Robert Prior, Constantin d’Ydewalle, Wanda Haeck, (unknown), Wendy Scheveneels, (unknown), M. Zameel Cader, Kevin Talbot, Alan P. Kozikowski, Pieter Vanden Berghe, Philip Van Damme, Wim Robberecht, Ludo Van Den Bosch	98
9	The Antisense Transcript SMN-AS1 Regulates SMN Expression and Is a Novel Therapeutic Target for Spinal Muscular Atrophy 2016 ·Neuron ·Constantin d’Ydewalle, Daniel M. Ramos, (unknown), Shi‐Yan Ng, (unknown), (unknown), Karen Ling, Lingling Kong, Amanda J. Ward, Lee L. Rubin, Frank Rigo, C. Frank Bennett, Charlotte J. Sumner	112
10	Spinal Muscular Atrophy Therapeutics: Where do we Stand? 2015 ·Neurotherapeutics ·Constantin d’Ydewalle, Charlotte J. Sumner	37
11	HDAC6 at the Intersection of Neuroprotection and Neurodegeneration 2012 ·Traffic ·Constantin d’Ydewalle, Elke Bogaert, Ludo Van Den Bosch	61
12	Charcot-Marie-Tooth disease: Emerging mechanisms and therapies 2012 ·The International Journal of Biochemistry & Cell Biology ·Constantin d’Ydewalle, Veronick Benoy, Ludo Van Den Bosch	29
13	HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1–induced Charcot-Marie-Tooth disease 2011 ·Nature Medicine ·Constantin d’Ydewalle, Jyothsna Krishnan, (unknown), Philip Van Damme, Joy Irobi, Alan P. Kozikowski, Pieter Vanden Berghe, Vincent Timmerman, Wim Robberecht, Ludo Van Den Bosch	375
14	Small Heat-Shock Protein HSPB1 Mutants Stabilize Microtubules in Charcot-Marie-Tooth Neuropathy 2011 ·Journal of Neuroscience ·Leonardo Almeida‐Souza, Bob Asselbergh, Constantin d’Ydewalle, Kristof Moonens, Sofie Goethals, Vicky De Winter, (unknown), Joy Irobi, Jean‐Pierre Timmermans, Kris Gevaert, Han Remaut, Ludo Van Den Bosch, Vincent Timmerman, Sophie Janssens	87
15	Amyotrophic Lateral Sclerosis and Excitotoxicity: From Pathological Mechanism to Therapeutic Target 2010 ·CNS & Neurological Disorders - Drug Targets ·Elke Bogaert, Constantin d’Ydewalle, Ludo Van Den Bosch	63
16	Effects of mental stress on autonomic cardiac modulation during weightlessness 2009 ·American Journal of Physiology-Heart and Circulatory Physiology ·André Aubert, B. Verheyden, Constantin d’Ydewalle, Frank Beckers, Omer Van den Bergh	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact